ResearchInsightful

🧪 Uprise D3 Lab Test Report + Why We Deleted the Bluvit Video ⚠️

Trustified

This video presents the lab test results for Uprise D3 vitamin D3 capsules, India's top-selling vitamin D3 supplement, confirming it meets its claimed 60,000 IU potency. The host also explains why a previously published video on Bluvit D3 was made private, citing the company's scientific explanation for their product testing over 97,000 IU. A notable concern is raised about the undisclosed gelatin source in Uprise D3 capsules.

Summary

The video begins with the host requesting viewers to subscribe and share the channel, emphasizing the significant effort and money spent on lab testing to help consumers make informed product choices. The channel is described as India's first and only 100% blind testing certification program.

The main focus is on Uprise D3, described as India's number one selling vitamin D3 capsule, commonly prescribed by doctors for vitamin D deficiency, weak bones, muscle weakness, fatigue, and improving calcium absorption. Each capsule contains 60,000 IU of vitamin D3, is priced at ₹350 for 12 capsules (approximately ₹29 per capsule), and is widely available at pharmacies.

The host explains the blind testing methodology: the product was ordered anonymously from a third-party seller to an anonymous address, and the same batch number product was sent directly to the lab for testing. The lab test results revealed 66,420.27 IU of vitamin D3 per capsule, which meets the company's claimed 60,000 IU potency, effectively passing the test.

However, an important concern is flagged: the capsule shell is made from gelatin, but the source of the gelatin is not disclosed by the manufacturer. The host notes that in the pharmaceutical industry, undisclosed gelatin sources typically derive from cows or pigs, which could be a concern for certain religious or dietary groups.

The second major topic covers why the Bluvit D3 video was made private. When tested across two independent labs, Bluvit D3 showed 97,000 IU despite claiming 60,000 IU — 1.5 times the claimed amount. The video was neither passed nor failed since it was not a case of underdosing or fake content. After the video's publication, Bluvit's company contacted the channel and explained that vitamin D3 naturally degrades over time, especially near expiry, so they intentionally include higher potency at manufacture to ensure customers receive at least the minimum claimed 60,000 IU by expiry. The host found this a scientifically reasonable explanation and decided to make the video private, as there was no evidence of underdosing or fraudulent content.

Key Insights

  • Uprise D3's lab test found 66,420.27 IU per capsule against a claimed 60,000 IU, confirming the product meets its stated potency and passes the blind test.
  • The host flags that Uprise D3's gelatin capsule shell has an undisclosed source, and in the pharmaceutical industry, undisclosed gelatin typically derives from cows or pigs, raising concerns for certain consumers.
  • Bluvit D3 was tested in two separate labs and found to contain 97,000 IU against a claimed 60,000 IU — over 1.5 times the stated amount — which led the channel to neither pass nor fail the product.
  • Bluvit's company argued that vitamin D3 gradually degrades over time, especially near expiry, so they intentionally start with higher potency to ensure the minimum claimed dose is available throughout the product's shelf life.
  • The channel uses an anonymous ordering process — ordering under an anonymous ID to an anonymous address from third-party sellers — to ensure genuine blind testing, with the same batch number sent directly to the lab.

Topics

Uprise D3 lab test resultsBlind testing methodologyGelatin source transparency concernBluvit D3 video retraction explanationVitamin D3 potency degradation over shelf life

Full transcript available for MurmurCast members

Sign Up to Access

Get AI summaries like this delivered to your inbox daily

Get AI summaries delivered to your inbox

MurmurCast summarizes your YouTube channels, podcasts, and newsletters into one daily email digest.